Over a dozen potential cannabis retailers on Guam remain in a holding pattern as the absence of a testing laboratory poses a significant hurdle for the budding marijuana industry.

Senator Will Parkinson convened a round-table hearing recently to assess the status of the marijuana sector and explore potential solutions to the testing dilemma.

During the hearing, an alternative proposal was discussed to address the absence of a testing lab – the implementation of an abatement clause.

The clause, if established, would waive the testing requirement if, for any reason, cannabis cannot be tested. However, if testing is possible, it must be conducted. The idea behind the abatement clause is to allow the industry to move forward, ensuring that either the businesses or the lab takes the initial step, breaking the current deadlock.

Public health officials suggested that if the clause were permitted, clear product packaging should indicate that the cannabis has not undergone testing.

“That way people are at least going into it with eyes wide open. Because as for myself I understand that no one's died from using cannabis. And so I'd feel pretty comfortable moving forward with a cannabis industry where we have some sort of waiver or abatement for cannabis testing as long as people know it.”

This transparency would empower consumers to make informed decisions about their purchases. While some individuals might be comfortable with untested products, others may find it crucial to have tested cannabis.

The proposed approach aims to balance the need for industry progress with consumers' right to knowledge about the products they are purchasing.

Senator Parkinson expressed his commitment to advancing the cannabis industry on Guam, considering the issue a high priority.

With recreational marijuana use legalized in 2019, the delay in the establishment of related businesses has been a source of frustration for potential entrepreneurs and consumers alike.